Scientists check if common anesthesia reversal drug reaches unborn babies
NCT ID NCT06634355
First seen Jan 09, 2026 · Last updated May 20, 2026 · Updated 22 times
Summary
This study aims to measure how much of the drug sugammadex crosses from a pregnant woman to her baby through the placenta. Researchers will use donated placentas from healthy pregnancies in a lab model. The results will help doctors understand potential risks to the fetus when this drug is used during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
Conditions
Explore the condition pages connected to this study.